Arrowstreet Capital Limited Partnership Has $762.98 Million Stock Position in Cigna Group $CI

Arrowstreet Capital Limited Partnership cut its position in Cigna Group (NYSE:CI) by 3.3% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,860,289 shares of the health services provider’s stock after selling 98,367 shares during the period. Arrowstreet Capital Limited Partnership’s holdings in Cigna Group were worth $762,982,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in the company. Wilkerson Advisory Group LLC acquired a new stake in shares of Cigna Group in the fourth quarter valued at $25,000. Beacon Financial Strategies CORP acquired a new position in Cigna Group during the 4th quarter worth about $28,000. Kemnay Advisory Services Inc. acquired a new position in Cigna Group during the 4th quarter worth about $29,000. Prosperity Bancshares Inc bought a new stake in Cigna Group during the 4th quarter worth about $29,000. Finally, Cedar Mountain Advisors LLC grew its holdings in Cigna Group by 161.9% during the 1st quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock worth $29,000 after acquiring an additional 68 shares during the last quarter. 86.99% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the company. The Goldman Sachs Group increased their price objective on Cigna Group from $335.00 to $340.00 and gave the company a “buy” rating in a research report on Monday, May 4th. Morgan Stanley upped their price target on Cigna Group from $355.00 to $361.00 and gave the company an “overweight” rating in a research note on Wednesday, May 20th. UBS Group raised their price target on Cigna Group from $375.00 to $400.00 and gave the company a “buy” rating in a report on Friday, May 22nd. Mizuho lifted their price objective on Cigna Group from $330.00 to $340.00 and gave the stock an “outperform” rating in a research report on Monday, June 8th. Finally, Sanford C. Bernstein boosted their price objective on Cigna Group from $371.00 to $381.00 and gave the stock an “outperform” rating in a report on Thursday, July 9th. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $338.80.

Insider Activity at Cigna Group

In other Cigna Group news, CEO David Cordani sold 201,878 shares of the firm’s stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the sale, the chief executive officer directly owned 34,337 shares in the company, valued at approximately $10,054,560.34. This trade represents a 85.46% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the company’s stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the transaction, the chief accounting officer owned 2,368 shares of the company’s stock, valued at $707,108.48. This trade represents a 27.52% decrease in their position. The SEC filing for this sale provides additional information. 0.60% of the stock is currently owned by insiders.

Cigna Group Stock Up 0.5%

Shares of NYSE CI opened at $286.32 on Friday. Cigna Group has a 52-week low of $239.51 and a 52-week high of $315.47. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73. The stock has a market cap of $75.74 billion, a P/E ratio of 12.14, a P/E/G ratio of 1.10 and a beta of 0.29. The firm has a 50 day moving average price of $285.95 and a 200 day moving average price of $280.71.

Cigna Group (NYSE:CI) last posted its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, topping the consensus estimate of $7.60 by $0.19. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The firm had revenue of $68.52 billion for the quarter, compared to analyst estimates of $66.29 billion. During the same period in the previous year, the company posted $6.74 earnings per share. The company’s revenue for the quarter was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Analysts expect that Cigna Group will post 30.39 EPS for the current year.

Cigna Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be issued a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. The ex-dividend date is Tuesday, September 8th. Cigna Group’s payout ratio is 26.45%.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.